Healthcare provider profile · identity verified

Thomas A. Bledsoe, MD

Internal Medicine · RIVERSIDE, RI · NPI 1245277953

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	696	186
Amlodipine Besylate	Amlodipine Besylate	354	93
Lisinopril	Lisinopril	342	92
Omeprazole	Omeprazole	306	79
Losartan Potassium	Losartan Potassium	274	69
Hydrochlorothiazide	Hydrochlorothiazide	254	70
Levothyroxine Sodium	Levothyroxine Sodium	226	52
Tamsulosin Hcl	Tamsulosin Hcl	219	59
Eliquis	Apixaban	199	38
Meloxicam	Meloxicam	178	46
Metoprolol Succinate	Metoprolol Succinate	178	53
Rosuvastatin Calcium	Rosuvastatin Calcium	159	44
Albuterol Sulfate Hfa	Albuterol Sulfate	125	42
Lorazepam	Lorazepam	123	27
Metoprolol Tartrate	Metoprolol Tartrate	122	33
Metformin Hcl	Metformin Hcl	116	30
Finasteride	Finasteride	114	25
Fluticasone Propionate	Fluticasone Propionate	114	39
Sertraline Hcl	Sertraline Hcl	113	24
Trazodone Hcl	Trazodone Hcl	110	28
Simvastatin	Simvastatin	101	25
Atenolol	Atenolol	96	27
Citalopram Hbr	Citalopram Hydrobromide	94	20
Furosemide	Furosemide	93	29
Pravastatin Sodium	Pravastatin Sodium	93	26
Metformin Hcl Er	Metformin Hcl	92	26
Ipratropium Bromide	Ipratropium Bromide	84	50
Escitalopram Oxalate	Escitalopram Oxalate	83	20
Gabapentin	Gabapentin	83	23
Paroxetine Hcl	Paroxetine Hcl	83	21
Allopurinol	Allopurinol	78	21
Lovastatin	Lovastatin	78	21
Terazosin Hcl	Terazosin Hcl	78	17
Jardiance	Empagliflozin	76	13
Montelukast Sodium	Montelukast Sodium	76	21
Alprazolam	Alprazolam	73	11
Clonazepam	Clonazepam	69	18
Synthroid	Levothyroxine Sodium	65	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	59	11
Pantoprazole Sodium	Pantoprazole Sodium	56	15
Alendronate Sodium	Alendronate Sodium	54	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	50	13
Duloxetine Hcl	Duloxetine Hcl	49	11
Chlorthalidone	Chlorthalidone	47	12
Pregabalin	Pregabalin	46	11
Tramadol Hcl	Tramadol Hcl	44	11
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	42	12
Meclizine Hcl	Meclizine Hcl	39	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	37	suppressed
Celecoxib	Celecoxib	36	suppressed
Bupropion Xl	Bupropion Hcl	35	suppressed
Glipizide Er	Glipizide	34	suppressed
Ibuprofen	Ibuprofen	34	suppressed
Clopidogrel	Clopidogrel Bisulfate	33	suppressed
Irbesartan	Irbesartan	32	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	31	suppressed
Xarelto	Rivaroxaban	31	suppressed
Mirtazapine	Mirtazapine	30	suppressed
Warfarin Sodium	Warfarin Sodium	28	suppressed
Famotidine	Famotidine	27	suppressed
Trulicity	Dulaglutide	27	suppressed
Glimepiride	Glimepiride	25	suppressed
Morphine Sulfate Er	Morphine Sulfate	24	suppressed
Ozempic	Semaglutide	24	suppressed
Spironolactone	Spironolactone	24	suppressed
Buprenorphine-Naloxone	Buprenorphine Hcl/Naloxone Hcl	23	suppressed
Buspirone Hcl	Buspirone Hcl	23	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	23	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	23	suppressed
Glipizide	Glipizide	22	suppressed
Methylprednisolone	Methylprednisolone	21	20
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	20	suppressed
Naproxen	Naproxen	19	suppressed
Oxycodone Hcl	Oxycodone Hcl	19	suppressed
Desloratadine	Desloratadine	18	suppressed
Diazepam	Diazepam	18	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	18	suppressed
Valsartan	Valsartan	18	suppressed
Alfuzosin Hcl Er	Alfuzosin Hcl	17	suppressed
Donepezil Hcl	Donepezil Hcl	17	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	17	suppressed
Diltiazem 24hr Er (La)	Diltiazem Hcl	16	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	16	suppressed
Methenamine Hippurate	Methenamine Hippurate	16	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	16	14
Pioglitazone Hcl	Pioglitazone Hcl	16	suppressed
Tizanidine Hcl	Tizanidine Hcl	16	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	15	suppressed
Fosinopril Sodium	Fosinopril Sodium	15	suppressed
Lidocaine	Lidocaine	15	suppressed
Ropinirole Hcl	Ropinirole Hcl	15	suppressed
Spiriva Handihaler	Tiotropium Bromide	15	suppressed
Toujeo Solostar	Insulin Glargine,hum.Rec.Anlog	15	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	15	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	14	suppressed
Diclofenac Sodium	Diclofenac Sodium	14	suppressed
Myrbetriq	Mirabegron	14	suppressed
Bisoprolol-Hydrochlorothiazide	Bisoprolol/Hydrochlorothiazide	13	suppressed
Breo Ellipta	Fluticasone/Vilanterol	13	suppressed
Buprenorphine	Buprenorphine	13	suppressed
Bupropion Hcl Sr	Bupropion Hcl	13	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	13	suppressed
Symbicort	Budesonide/Formoterol Fumarate	13	suppressed
Testosterone	Testosterone	13	suppressed
Arnuity Ellipta	Fluticasone Furoate	12	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	12	suppressed
Omega-3 Acid Ethyl Esters	Omega-3 Acid Ethyl Esters	12	suppressed
Ondansetron Hcl	Ondansetron Hcl	12	suppressed
Potassium Chloride	Potassium Chloride	12	suppressed
Prednisone	Prednisone	12	11
Sucralfate	Sucralfate	12	suppressed
Valacyclovir	Valacyclovir Hcl	12	suppressed
Ventolin Hfa	Albuterol Sulfate	12	suppressed
Acyclovir	Acyclovir	11	suppressed
Humalog Kwikpen U-200	Insulin Lispro	11	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error